| UCB-Pharma SA - Briviact 50 mg, comprimés pelliculés | | 65831 | | 03 | | Briviact 50 mg | | comprimés pelliculés | | N03AX23 | | Brivaracetam | | 06.10.2016 | | |
| | Composition | | brivaracetamum 50 mg, carmellosum natricum conexum corresp. natrium 1.5 mg, lactosum monohydricum 97 mg, betadexum, lactosum 96.5 mg, magnesii stearas, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, E 171, E 172 (flavum), E 172 (rubrum) pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Brivaracetamum | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Brivaracetamum | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) pro Compresso Obducto | | | | Betadexum | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Lactosum | 96.5 mg | | | Lactose Monohydrate | 97 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | pellicule | | Talcum | | |
| |
| |
|
